Ketamine and Blood Pressure Medication: What to Know

Can You Take Ketamine With Blood Pressure Medication?

In most cases, yes, if a licensed clinician determines it is medically appropriate. The medication itself is rarely the deciding factor.

What matters more is how well your blood pressure is controlled and whether a clinician screens and monitors you. Mindbloom treats at-home ketamine therapy safety as a function of screening, oversight, and protocols, not the drug list alone.

Whether ketamine and blood pressure medication can be safely combined depends on your blood pressure control, not any single drug. The main situation where ketamine is not appropriate is uncontrolled hypertension. The ketamine prescribing label contraindicates it where a significant rise in blood pressure would be a serious hazard.¹ Related concerns include a recent heart attack, aortic problems, or an aneurysm.

How Ketamine Affects Blood Pressure

Ketamine has a well-characterized, temporary effect on the cardiovascular system. That effect is the reason cardiovascular screening and blood-pressure monitoring are built into treatment.

The two questions readers ask most are why blood pressure rises and how much. The sections below answer each in turn, using therapeutic (sub-anesthetic) dosing rather than the higher anesthetic doses used in surgery.

Why Ketamine Temporarily Raises Blood Pressure

Some people experience a temporary rise in blood pressure and heart rate during a session. It happens because ketamine has sympathomimetic properties, meaning it briefly stimulates the cardiovascular system.

In practical terms, ketamine prompts a short-lived release of the body's own stimulating chemicals, which nudges heart rate and blood pressure upward for a while. You can read more about ketamine's temporary side effects and why they occur.

Because this effect is expected, your vitals are watched throughout a session. The ketamine prescribing label notes that blood pressure and pulse are frequently elevated after it is given.¹

How Much Blood Pressure Rises and How Long It Lasts

At therapeutic (sub-anesthetic) doses, the average rise is modest and transient. It usually returns toward baseline within one to two hours.

A 2021 Frontiers in Psychiatry meta-analysis pooled 2,252 sub-anesthetic treatments (Vankawala and colleagues). The average maximum increase was about 12.6 mmHg systolic and 8.5 mmHg diastolic, and it was transient.³

A 2018 Journal of Affective Disorders study of 684 infusions reported small increases (Riva-Posse and colleagues). At 30 minutes the largest mean rise was about 3.3 mmHg systolic and 3.2 mmHg diastolic, even though 36.1% of patients had essential hypertension.⁴

Averages do not capture everyone. A 2024 General Hospital Psychiatry analysis reviewed 2,342 infusions (Ansari and colleagues). A severe surge appeared in 17 of 138 patients, about 1 in 8 (12.5%).⁵ It occurred in under 1% of infusions (23 of 2,342) and clustered in the first three sessions.

That individual tail, not the average, is what monitoring exists to catch. These figures come from intravenous and intranasal studies.

Mindbloom offers two at-home routes, sublingual and subcutaneous, chosen with your clinician based on comfort, preference, tolerability, and clinical fit. Applying intravenous and intranasal numbers to those routes is a reasonable but stated extrapolation.

For contrast, the ketamine prescribing label describes higher anesthetic-dose effects, where blood pressure usually returns to preanesthetic values within 15 minutes.¹ Anesthetic dosing is far higher than the doses used for mental health. That is why those surgical figures do not describe a therapy session.

When Blood Pressure Makes Ketamine Unsafe

Eligibility is a clinician's judgment based on your whole health picture, not a single reading. It is a medical assessment, not a fixed rulebook.

The two questions that follow are what "controlled" blood pressure means and which conditions make ketamine inappropriate. Both are answered below.

Controlled vs. Uncontrolled Hypertension

"Controlled" means stable, consistent readings on a treatment plan you and your prescriber have established. Uncontrolled means high or erratic readings without a stable plan in place. People with hypertension can still be candidates when their numbers are steady.

Mindbloom applies a tiered screening approach as one provider's example of how this works. It generally requires no extra clearance when blood pressure is well controlled below 140/90 on three or fewer medications. It asks for medical clearance when someone takes four or more medications or has a cardiac or neurological condition.

Mindbloom does not administer a session when the pre-session reading is roughly above 150/100 or the resting heart rate is over 100. These thresholds are Mindbloom's screening criteria, not universal cutoffs, and your own provider sets any thresholds for your care. You can review who is not a candidate for more detail.

When Ketamine Is Not Appropriate

A contraindication is a specific reason a treatment should not be used. Some call for added caution and case-by-case judgment, while others may make treatment inappropriate depending on the condition and clinical context. For more background, see what a contraindication means.

For blood pressure and the heart, a temporary rise is a genuine hazard in a few situations. These include uncontrolled hypertension, a recent heart attack, unstable angina, a history of aortic dissection or aneurysm, and other serious cardiovascular disease. In those conditions, even a short-lived increase in blood pressure can strain a vessel or an already-stressed heart.

Regulatory and medical sources use precise language here. The ketamine prescribing label states it is contraindicated in those for whom a significant elevation of blood pressure would constitute a serious hazard.¹ Screening is designed to identify these situations before treatment begins.

Ketamine and Blood Pressure Medication: Common Classes

Here is the general rule: most blood pressure medications are compatible with ketamine and should be continued as prescribed, not skipped on session day. Disclosing them lets your provider see the full picture.

The table below summarizes how each common class interacts and how it is typically handled. Each class is then covered in its own section.

Mindbloom's guide to ketamine drug interactions covers how each of these is managed on treatment days.

Beta Blockers

Beta blockers such as metoprolol, atenolol, and propranolol are generally continued as prescribed. The interaction is not fully characterized at psychiatric ketamine doses, and the evidence points in two directions. Older animal data show propranolol blunting ketamine's blood-pressure rise (Kaukinen 1978), so beta blockers may actually temper the response. A theoretical "unopposed alpha" concern, that beta blockade could leave alpha receptors free to drive a sharper rise as ketamine raises norepinephrine, is extrapolated from the stimulant literature and remains unproven for ketamine. The practical takeaway is clinician awareness, not a reason to avoid either drug.

Your provider manages the timing, and you take the medication as prescribed. There is no need to stop a beta blocker on your own before a session.

ACE Inhibitors and ARBs

ACE inhibitors like lisinopril and ARBs like losartan are generally compatible and continued as prescribed. They do not have a notable direct interaction with ketamine's cardiovascular effect.

Still, disclose them so your provider has the complete medication list. Full disclosure supports safe, personalized care.

Calcium Channel Blockers and Diuretics

Calcium channel blockers such as amlodipine and diltiazem are generally compatible and continued as prescribed. They do not have a meaningful direct interaction with ketamine.

Diuretics are generally compatible too. Disclose them, because hydration and electrolyte balance can influence how you feel during a session, so your provider may offer simple guidance.

Clonidine and Other Alpha-2 Agonists

Clonidine and other alpha-2 agonists lower sympathetic outflow, so they are generally compatible. In some medical settings, medications in this group are even used to help temper ketamine's blood-pressure response.

Treat that as provider-managed context, not a self-directed step. Continue clonidine as prescribed and let your provider handle timing.

Medication Combinations That Raise Cardiovascular Risk

Unlike most blood pressure drugs, a few medications add to ketamine's cardiovascular load and deserve closer attention. The two that matter most here are stimulants and MAOIs.

Both are usually manageable with disclosure and monitoring, and occasionally a session-day timing adjustment. Mindbloom's guide to combining ketamine with other medications walks through how each is handled.

Stimulants

Stimulants such as Adderall (amphetamine), methylphenidate, and lisdexamfetamine both raise heart rate and blood pressure, and so does ketamine. Together, the effect can be additive, which matters most for people whose baseline blood pressure is already elevated.

This is generally a moderate interaction that warrants disclosure and closer monitoring. The esketamine prescribing label directs close blood-pressure monitoring when it is used alongside psychostimulants.² Many people who take prescribed stimulants remain candidates, and any timing adjustment is a provider decision.

MAOIs

Monoamine oxidase inhibitors (MAOIs) carry one of the more clinically significant interaction profiles with ketamine. Both can raise norepinephrine activity, which can exaggerate a blood-pressure rise, with a theoretical risk of serotonin-related effects.

MAOIs are uncommon in current practice. When one is present, it calls for thorough evaluation and may be a true contraindication depending on the specific drug and your cardiovascular profile. The esketamine prescribing label also directs close blood-pressure monitoring in patients receiving MAOIs.²

Monitoring Your Blood Pressure During Treatment

A blood-pressure check happens before a session, and a session is not administered if the reading is too high. Monitoring is the practical way risk is managed, building on the screening described earlier.

Mindbloom's at-home model pairs provider screening with a required in-person peer treatment monitor and a blood-pressure monitor included in the Bloombox. The provider sets any thresholds. The peer treatment monitor must be present during your session and the post-session transition.

Take your blood pressure medication as prescribed on session day, and do not skip doses. Continuing your antihypertensive medication keeps your numbers steady when it counts.

Disclose your full list of medications, supplements, and substances. Disclosure is a safety step that helps your provider personalize care, not a way to screen you out.

Building on decades of clinical research on ketamine's safety, Mindbloom's published outcomes add real-world data. In Mindbloom's peer-reviewed, real-world outcomes, serious adverse events occurred in fewer than 0.1% of clients: 0.05% among 11,441 sublingual clients (Mathai et al. 2024) and 0.08% among 3,041 subcutaneous clients (Parks et al. 2026).⁶⁻⁷ Results reflect Mindbloom's clients, and individual results may vary.

You can also review how medically supervised ketamine sessions work.

Preparing for Treatment if Your Blood Pressure Is Borderline

If your blood pressure sits near the line, you have concrete steps before treatment. The goal is steady, well-controlled readings, and that work belongs to you and your prescriber.

Start by working with your prescriber to optimize your regimen, and take your medication consistently. Well-established lifestyle steps support control over a few weeks:

• Reduce sodium: Lowering salt intake can help bring readings down.
• Limit alcohol and excess caffeine: Both can push blood pressure up.
• Stay active: Regular movement supports healthier blood pressure over time.

Bring a current medication list and a home blood-pressure log to your screening. Re-evaluation is possible once your blood pressure is stable, so a borderline reading today is a starting point, not a dead end.